Invited Faculty
  • Evelyne Vinet
    McGill Univ. Health Centre
    Canada
  • Dr. Évelyne Vinet, MD, PhD
    Fonds de recherche du Québec-Santé Clinical Research Scholar Junior 2
    The Arthritis Society Stars Career Development Award
    Associate Professor, Divisions of Rheumatology & Clinical Epidemiology,
    McGill University Health Centre (MUHC)
    Full Member, Division of Experimental Medicine, McGill University
    Associate Member, Dept. of Epidemiology, Biostatistics, and Occupational Health, McGill University
    Medical Scientist, Centre for Outcome Research & Evaluation (CORE), Research Institute of the McGill University Health Centre (RI-MUHC)
    Dr. Évelyne Vinet is an associate professor in the Division of Rheumatology at McGill University. She is also a medical scientist for the Centre for Health Outcomes Research at the Research Institute of the McGill University Health Centre (MUHC), an associate member of the McGill Department of Epidemi-ology, Biostatistics and Occupational Health and a full member of the McGill Division of Experimental Medicine. Dr. Vinet is an attending staff at the MUHC Lupus & Vasculitis clinic and she leads the MUHC Rheumatology & Reproduction clinic. The primary goal of Dr. Vinet’s research program is to use epidemiologic methods to improve reproductive health outcomes in women with rheumatic diseases, such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). To this end, Dr. Vinet has created the world's largest cohort of offspring born to SLE women, which has driven her novel findings demon-strating that SLE offspring are at increased risk of autism spectrum disorders, congenital heart defects, and stillbirths. Dr. Vinet is also actively spear-heading research initiatives to elucidate how therapies used to treat rheumatic diseases (e.g. TNF inhibitors and other biologics) impact health outcomes in these pa-tients and their offspring. Dr. Vinet has been an active committee member of the 2020 American College of Rheumatology guidelines on reproductive health in rheumatic diseases. Finally, Dr. Vinet is leading an international multi-centre prospective cohort study of lupus pregnancies, the “Lupus in prEGnACY (LEGACY)” cohort, to allow early risk stratification and personalized therapy of pregnancies.
    Research & Clinical Focus

    systemic lupus erythematosus (SLE)

    Rheumatoid Arthritis (RA)

    female reproductive health

    pregnancy and rheumatic diseases

    Administrative Databases

    • Date Time Room Session Title Lecture Title
    May 17 13:50-14:10 Room Grand Ballroom 102 [Study Group Session] The Systemic Lupus Erythematosus International Collaborating Clinics Group (SLICC) Study Group Session Pregnancy
    May 19 09:15-09:45 Room Room 205A+B [Meet the Professor 6] Managing Lupus Pregnancy Managing lupus pregnancy